Aptus Therapeutics-backed Alzheon has set its pricing range at $13 to $15 and could raise almost $86.3m if underwriters take up their option to purchase additional shares.

Unum Therapeutics has listed on the Nasdaq Global Select Market, providing exits to Novo, Sanofi, EMS and Seattle Genetics.

Novartis-backed Homology Medicines priced its shares at $16 and raised $165m when it floated on the Nasdaq Global Select Market.

The corporate has agreed to acquire Mobike, backed by Tencent, for $2.7bn.

Following reports in February, Alibaba has confirmed it will acquire the remaining shares in Ele.me, currently owned by investors such as JD.com, Tencent and Baidu.

The file storage cloud platform Dropbox floated above the original range it had set in an oversubscribed IPO which valued it at over $8bn.

Given the rise of intangibles in the economy, control versus delegation strikes at the heart of modern business practices. If or whether both Tencent and Alibaba continue to perform as well in the future might reflect their approaches in management.

Lytro, which had raised more than $200m from investors including Qualcomm, Foxconn and Huayi Brothers, has closed.

Qualcomm Ventures has exited agricultural management platform developer Strider in an acquisition of undisclosed size by Syngenta.

The digital signature technology provider, backed by Dell, Intel, Salesforce, Telstra, Visa, Deutsche Telekom, Samsung, NTT, Mitsui, BBVA, Alphabet and Comcast, has filed for a $100m IPO.